Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-064122

Chief Legal Officer gave up 498 shares (to pay taxes)

  • Chief Legal Officer acquired 1,734 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ali-Jackson Kamil Chief Legal Officer 2020-12-15 Option exercise +1,734 124,587 D
Ali-Jackson Kamil Chief Legal Officer 2020-12-15 Shares withheld for taxes −498 $4.59 $2,286 124,089 D
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2020-12-15 Option exercise · Restricted Stock Units −1,734 0 D
Loading xslF345X03/doc4.xml…